La. Admin. Code tit. 46 § XLV-4506

Current through Register Vol. 50, No. 9, September 20, 2024

Section XLV-4506 - Services Performed by Physician Assistants Registered to Prescribe Medication or Medical Devices; Prescription Forms; Prohibitions

1. A physician assistant who is registered with the board pursuant to §1521 of these rules to prescribe medication and/or medical devices may, to the extent delegated by a supervising physician:

a. issue prescriptions for medication or medical devices to a patient of the supervising physician;

b. transmit orally, electronically, or in writing on a patient's record a prescription or order to an individual who may lawfully furnish such medication or medical device; and

c. request, receive, sign for and deliver to a patient a bona fide medication sample.

2. The medical record of any patient for whom the physician assistant has prescribed medication or a medical device, or delivered a bona fide medication sample, shall be properly documented by the physician assistant.

B. All prescriptions issued by a physician assistant shall include:

1. the preprinted name, address, prescriptive authority registration number (license number), and telephone number of the physician assistant;

2. the patient's name and the date the prescription is written;

3. whether generic substitution is authorized, and if not:

a. the physician assistant shall check a box labeled "Dispense as Written" or "DAW" or both; and

b. for prescriptions reimbursable by Medicare and Medicaid, the physician assistant may only inhibit equivalent drug product interchange by handwriting the words "brand necessary" or "brand medically necessary" on the face of the prescription order or on a separate sheet attached to the prescription order;

4. the number of refills, if any; and

5. for a controlled substance, a space in which the physician assistant shall legibly print his DEA number.

C. A physician assistant who has been delegated prescriptive authority shall not:

1. utilize prescriptive authority without supervision, as defined by §1503, or at any location other than specified in the supervising physician's registration of delegation of prescriptive authority filed with the board, except in life-threatening emergencies;

2. prescribe medication or medical devices:

a. except to the extent delegated by a supervising physician, as evidenced by approval of registration on file with the board in accordance with §1507-1527 of these rules;

b. beyond the physician assistant's education, training and experience;

c. outside of his specialty or that of the supervising physician;

d. in the absence of clinical practice guidelines or protocols specified by §1527;

e. except in compliance with all applicable state and federal laws and regulations;

f. when the supervising physician, or in his absence an approved locum tenens physician, and physician assistant do not have the capability to be in contact with each other by telephone or other telecommunication.

3. treat and/or utilize controlled substances in connection with the treatment of:

a. non-cancer related chronic or intractable pain, as set forth in §6915-6923 of the board's rules;

b. obesity, as set forth in §6901-6913 of the board's rules;

c. one's self, spouse, child or any immediate family member except in a life-threatening emergency;

4. sell or dispense medication, as set forth in §6501-6561 of the board's rules;

5. issue a prescription or order for any schedule I controlled substance contained or hereinafter included in R.S. 40:964; or

6. dispense or deliver any controlled substance sample.

D. A PA who has been delegated controlled substance prescriptive authority shall enroll in and periodically accesses the Prescription Monitoring Program (PMP) established by R.S. 40:1001 et seq.

La. Admin. Code tit. 46, § XLV-4506

Promulgated by the Department of Health and Hospitals, Board of Medical Examiners, LR 31:79 (January 2005), Amended by LR 41925 (5/1/2015), Amended by the Department of Health, Board of Medical Examiners, LR 431178 (6/1/2017), Amended LR 45554 (4/1/2019).

AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1270(B)(6), 37:1360.23(D) and (F) six, and 37:1360.31(B)(8).